Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,441,917 papers from all fields of science
Search
Sign In
Create Free Account
Pirarubicin
Known as:
Adriamycin, tetrahydropyranyl
, THP-adriamycin
, (2"R)-4'-O-Tetrahydropyranyladriamycin
Expand
An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (2)
Antineoplastic Agents
Doxorubicin
NCIt Antineoplastic Agent Terminology
analogs & derivatives
Narrower (4)
Pinorubicin
Theprubicin
pirarubicin hydrochloride
therarubicin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.
D. Kong
,
Shumei Ma
,
+7 authors
Xiaodong Liu
Biomedicine & pharmacotherapy = Biomedecine…
2012
Corpus ID: 24522369
Highly Cited
2010
Highly Cited
2010
In vitro and in vivo evaluation of tumor targeting styrene‐maleic acid copolymer‐pirarubicin micelles: Survival improvement and inhibition of liver metastases
Jurstine Daruwalla
,
M. Nikfarjam
,
+4 authors
H. Maeda
Cancer Science
2010
Corpus ID: 32720936
Pirarubicin is a derivative of doxorubicin with improved intracellular uptake and reduced cardiotoxicity. We have prepared a…
Expand
Highly Cited
2007
Highly Cited
2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
K. Kudo
,
S. Kojima
,
+12 authors
I. Tsukimoto
Journal of Clinical Oncology
2007
Corpus ID: 21406443
PURPOSE To evaluate a less intensive chemotherapeutic regimen specifically designed for patients with Down syndrome (DS) and…
Expand
Highly Cited
2005
Highly Cited
2005
Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity
G. Braslawsky
,
K. Kadow
,
+4 authors
R. Greenfield
Cancer Immunology and Immunotherapy
2005
Corpus ID: 26510914
SummaryAdriamycin hydrazone (ADM-Hzn) immunoconjugates have previously been shown to exhibit antibody-directed antitumor activity…
Expand
Review
2004
Review
2004
TRAIL and chemotherapeutic drugs in cancer therapy.
Xiuxian Wu
,
O. Ogawa
,
Y. Kakehi
Vitamins and hormones
2004
Corpus ID: 45575249
Highly Cited
1997
Highly Cited
1997
Doxorubicin sensitizes human bladder carcinoma cells to Fas‐mediated cytotoxicity
Y. Mizutani
,
Y. Okada
,
O. Yoshida
,
M. Fukumoto
,
B. Bonavida
Cancer
1997
Corpus ID: 24709639
The resistance of bladder carcinoma to anticancer chemotherapeutic agents remains a major problem. Hence, several…
Expand
1996
1996
Pyrazole-related nucleosides. 4. Synthesis and antitumor activity of some 1-tetrahydropyranyl-4-substituted pyrazoles.
S. Manfredini
,
R. Bazzanini
,
+8 authors
P. La Colla
Anti-Cancer Drug Design
1996
Corpus ID: 6409955
Continuing our studies on the structure-activity relationships of some pyrazole nucleosides (1a-h) structurally related to…
Expand
Highly Cited
1989
Highly Cited
1989
Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.
B. Schott
,
J. Robert
Biochemical Pharmacology
1989
Corpus ID: 24360858
1988
1988
Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.
N. Maniar
,
A. Krishan
,
M. Israel
,
T. Samy
Biochemical Pharmacology
1988
Corpus ID: 24266553
Highly Cited
1986
Highly Cited
1986
Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
A. Krishan
,
A. Sauerteig
,
K. Gordon
,
C. Swinkin
Cancer Research
1986
Corpus ID: 17172553
Cellular accumulation of daunorubicin (DNR), N-trifluoroacetyl-adriamycin-14-valerate, and THP-Adriamycin (THP-ADR) in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE